(XSX7) Xtrackers Stoxx Europe 600 - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2581375156
XSX7: Large Companies, European Stocks, Equity Securities, Blend Investments
The Xtrackers Stoxx Europe600 UCITS ETF1D (XETRA:XSX7) is a Germany-originated ETF that tracks the Morningstar DM Eur TME NR EUR Index, providing exposure to Europes large-cap blend equity segment. As a Europe Large-Cap Blend Equity ETF, it offers diversified investment in the regions top companies.
Analyzing the ETFs technical data, we observe a current price of 86.51, slightly above its 20-day Simple Moving Average (SMA) of 85.93, indicating a short-term bullish trend. The 50-day SMA at 82.47 and 200-day SMA at 80.85 further reinforce this trend, as the price is significantly above these longer-term averages. The Average True Range (ATR) stands at 0.80, translating to a volatility of 0.92%. The ETFs price has been within a 52-week range of 72.38 to 86.76, with the current price near the upper end of this range.
From a fundamental perspective, the ETF boasts an Assets Under Management (AUM) of 3452.44M EUR, indicating a substantial investor base and liquidity. This sizeable AUM suggests that the ETF is a popular choice among investors seeking Europe large-cap exposure.
Combining technical and fundamental insights, we can forecast that XSX7 is likely to continue its upward trend in the short term, driven by its bullish technical indicators and the overall strength of the European large-cap equity market. However, the proximity to the 52-week high and relatively low ATR may indicate a potential consolidation or slight correction in the near future. Investors should monitor the ETFs ability to sustain its price above the 85.93 SMA level and watch for any changes in the broader European market trends.
Based on the current technical and fundamental data, a potential trading strategy could involve buying XSX7 on dips towards the 85.93 SMA, with a target price above the current 52-week high of 86.76, and a stop-loss below the 82.47 SMA to limit potential losses. This strategy would require continuous monitoring of the ETFs price action and adjustments to the stop-loss and target price as necessary.
Additional Sources for XSX7 ETF
XSX7 ETF Overview
Market Cap in USD | 4,049m |
Category | Europe Large-Cap Blend Equity |
IPO / Inception | 2023-03-08 |
XSX7 ETF Ratings
Growth Rating | 54.7 |
Fundamental | - |
Dividend Rating | 41.4 |
Rel. Strength | -6.54 |
Analysts | - |
Fair Price Momentum | 81.61 EUR |
Fair Price DCF | - |
XSX7 Dividends
Dividend Yield 12m | 2.58% |
Yield on Cost 5y | 3.34% |
Annual Growth 5y | 24.35% |
Payout Consistency | 100.0% |
Payout Ratio | % |
XSX7 Growth Ratios
Growth Correlation 3m | 71.5% |
Growth Correlation 12m | 66.5% |
Growth Correlation 5y | 90.9% |
CAGR 5y | 13.44% |
CAGR/Max DD 5y | 0.82 |
Sharpe Ratio 12m | 1.15 |
Alpha | -1.93 |
Beta | 0.548 |
Volatility | 12.68% |
Current Volume | 1.6k |
Average Volume 20d | 4.2k |
As of July 01, 2025, the stock is trading at EUR 84.72 with a total of 1,601 shares traded.
Over the past week, the price has changed by +1.18%, over one month by -1.17%, over three months by +2.94% and over the past year by +8.55%.
Partly, yes. Based on ValueRay´s Analyses, Xtrackers Stoxx Europe 600 (XETRA:XSX7) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.74 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XSX7 is around 81.61 EUR . This means that XSX7 is currently overvalued and has a potential downside of -3.67%.
Xtrackers Stoxx Europe 600 has no consensus analysts rating.
According to our own proprietary Forecast Model, XSX7 Xtrackers Stoxx Europe 600 will be worth about 92.1 in July 2026. The stock is currently trading at 84.72. This means that the stock has a potential upside of +8.75%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 92.1 | 8.7% |